Alcohol, Breast Cancer, and Metabolism
ABC-Met
Localized Mammary Alcohol Metabolism as a Mechanism Linking Low-Level Alcohol Intake to Breast Cancer Risk
1 other identifier
interventional
50
1 country
1
Brief Summary
Alcohol consumption, even at low levels, has been associated with increased breast cancer risk, but the biological mechanisms underlying this relationship remain unclear. This study will examine whether breast tissue may locally metabolize alcohol by measuring alcohol-related compounds in paired blood and breast milk samples from lactating women. The findings may help clarify alcohol-related biological pathways relevant to breast cancer risk and improve risk communication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2026
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2026
CompletedFirst Posted
Study publicly available on registry
August 21, 2026
CompletedStudy Start
First participant enrolled
September 3, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 13, 2031
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2032
September 8, 2026
September 1, 2026
4.9 years
August 18, 2026
September 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Blood alcohol concentrations
Alcohol concentrations in blood
2- 3 weeks
Milk alcohol concentration
Concentration of alcohol in breast milk
2- 3 weeks
Milk acetaldehyde
Concentration of acetaldehyde in human milk
1-3 weeks
Blood acetaldehyde
Concentration of acetaldehyde in blood
1- 3 weeks
Study Arms (3)
Arm 1: lactating women dose response
EXPERIMENTALLactating women who will drink \~0, 1 or 2 standard drinks of alcohol
Arm 2: timing of pumping
EXPERIMENTALLactating women will pump at two different times from alcohol drinking and at one of these times after placebo drinking
Aim 3: non-lactating control women
OTHERNon-lactating women of similar age, BMI, and alcohol consumption characteristics will drink a similar dose of alcohol as lactating women for the assessment of systemic alcohol-related measurements. This group will serve as a comparison group for interpreting alcohol-related measurements in lactating participants.
Interventions
Participants will consume a protocol-specified low-level alcohol exposure under study conditions. The assigned dose and biospecimen collection procedures will vary by study group.
Breast pumping before or after drinking \~ 1 standard drink or placebo drink
Eligibility Criteria
You may qualify if:
- All aims
- Drink alcohol (at least one alcoholic drink during lactation of a lactating female)
- For aims 1 and 2
- Nursing a 2- to 5-month-old infant
- Experienced with a breast pump
You may not qualify if:
- Pregnant
- Lifetime history of alcohol dependence
- Drink more than 3 standard drinks per day or more than 7 standard drinks per week in the month previous to enrollment
- Current regular use of drugs with addiction potential (other than alcohol)
- Use of medications known to interact with alcohol metabolism
- Current smoking
- Anemia
- Diabetes
- Liver disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bevier Hall; University of Illinois at Urbana Champaign
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta Y Pepino de Gruev
University of Illinois at Urbana-Champaign
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2026
First Posted
August 21, 2026
Study Start
September 3, 2026
Primary Completion (Estimated)
July 13, 2031
Study Completion (Estimated)
March 1, 2032
Last Updated
September 8, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF
- Time Frame
- From the end of the grant until NIAAA Da allows it.
- Access Criteria
- The data will be shared with NIAAA DA and they will determine the protocol to access.
* De-identified participant demographic and screening variables (e.g., age, BMI, lactation characteristics) * Alcohol dosing information based on measured fat-free mass * Time-resolved physiological and pharmacokinetic data (e.g., blood alcohol concentration, breath alcohol concentration, elimination rates, AUC) * Quantitative biochemical measurements of ethanol and acetaldehyde concentrations in paired human milk and blood samples obtained using headspace gas chromatography with flame ionization detection (HS-GC-FID) * Derived variables generated for statistical and pharmacokinetic analyses